Despite the unaltered AMPAR protein expression levels in APP/PS1 mice, we explored the possibility that they may still undergo changes in the synaptic localization vs. intracellular sites with AD progression, as also recently described for GABAB receptors (Martín-Belmonte et al., 2019). Here, APP is linked to Alzheimer disease.